The Market Reports

Index

1 Genetically Engineered Vector Vaccine Market Overview
1.1 Product Overview and Scope of Genetically Engineered Vector Vaccine
1.2 Genetically Engineered Vector Vaccine Segment by Type
1.2.1 Global Genetically Engineered Vector Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Viral Vector Vaccine
1.2.3 Plasmid Vector Vaccine
1.2.4 VLPV
1.2.5 RNA Vaccine
1.3 Genetically Engineered Vector Vaccine Segment by Application
1.3.1 Global Genetically Engineered Vector Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Genetically Engineered Vector Vaccine Market Size Estimates and Forecasts
1.4.1 Global Genetically Engineered Vector Vaccine Revenue 2019-2030
1.4.2 Global Genetically Engineered Vector Vaccine Sales 2019-2030
1.4.3 Global Genetically Engineered Vector Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Genetically Engineered Vector Vaccine Market Competition by Manufacturers
2.1 Global Genetically Engineered Vector Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Genetically Engineered Vector Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Genetically Engineered Vector Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Genetically Engineered Vector Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genetically Engineered Vector Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetically Engineered Vector Vaccine, Product Type & Application
2.7 Genetically Engineered Vector Vaccine Market Competitive Situation and Trends
2.7.1 Genetically Engineered Vector Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetically Engineered Vector Vaccine Players Market Share by Revenue
2.7.3 Global Genetically Engineered Vector Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetically Engineered Vector Vaccine Retrospective Market Scenario by Region
3.1 Global Genetically Engineered Vector Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Genetically Engineered Vector Vaccine Global Genetically Engineered Vector Vaccine Sales by Region: 2019-2030
3.2.1 Global Genetically Engineered Vector Vaccine Sales by Region: 2019-2024
3.2.2 Global Genetically Engineered Vector Vaccine Sales by Region: 2025-2030
3.3 Global Genetically Engineered Vector Vaccine Global Genetically Engineered Vector Vaccine Revenue by Region: 2019-2030
3.3.1 Global Genetically Engineered Vector Vaccine Revenue by Region: 2019-2024
3.3.2 Global Genetically Engineered Vector Vaccine Revenue by Region: 2025-2030
3.4 North America Genetically Engineered Vector Vaccine Market Facts & Figures by Country
3.4.1 North America Genetically Engineered Vector Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Genetically Engineered Vector Vaccine Sales by Country (2019-2030)
3.4.3 North America Genetically Engineered Vector Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Genetically Engineered Vector Vaccine Market Facts & Figures by Country
3.5.1 Europe Genetically Engineered Vector Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Genetically Engineered Vector Vaccine Sales by Country (2019-2030)
3.5.3 Europe Genetically Engineered Vector Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Genetically Engineered Vector Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Genetically Engineered Vector Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Genetically Engineered Vector Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Genetically Engineered Vector Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Genetically Engineered Vector Vaccine Market Facts & Figures by Country
3.7.1 Latin America Genetically Engineered Vector Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Genetically Engineered Vector Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Genetically Engineered Vector Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetically Engineered Vector Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetically Engineered Vector Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Genetically Engineered Vector Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Genetically Engineered Vector Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genetically Engineered Vector Vaccine Sales by Type (2019-2030)
4.1.1 Global Genetically Engineered Vector Vaccine Sales by Type (2019-2024)
4.1.2 Global Genetically Engineered Vector Vaccine Sales by Type (2025-2030)
4.1.3 Global Genetically Engineered Vector Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Genetically Engineered Vector Vaccine Revenue by Type (2019-2030)
4.2.1 Global Genetically Engineered Vector Vaccine Revenue by Type (2019-2024)
4.2.2 Global Genetically Engineered Vector Vaccine Revenue by Type (2025-2030)
4.2.3 Global Genetically Engineered Vector Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Genetically Engineered Vector Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Genetically Engineered Vector Vaccine Sales by Application (2019-2030)
5.1.1 Global Genetically Engineered Vector Vaccine Sales by Application (2019-2024)
5.1.2 Global Genetically Engineered Vector Vaccine Sales by Application (2025-2030)
5.1.3 Global Genetically Engineered Vector Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Genetically Engineered Vector Vaccine Revenue by Application (2019-2030)
5.2.1 Global Genetically Engineered Vector Vaccine Revenue by Application (2019-2024)
5.2.2 Global Genetically Engineered Vector Vaccine Revenue by Application (2025-2030)
5.2.3 Global Genetically Engineered Vector Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Genetically Engineered Vector Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Genetically Engineered Vector Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Genetically Engineered Vector Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Genetically Engineered Vector Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Wantai Biotechnology
6.4.1 Wantai Biotechnology Corporation Information
6.4.2 Wantai Biotechnology Description and Business Overview
6.4.3 Wantai Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wantai Biotechnology Genetically Engineered Vector Vaccine Product Portfolio
6.4.5 Wantai Biotechnology Recent Developments/Updates
6.5 Watson Bio
6.5.1 Watson Bio Corporation Information
6.5.2 Watson Bio Description and Business Overview
6.5.3 Watson Bio Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Watson Bio Genetically Engineered Vector Vaccine Product Portfolio
6.5.5 Watson Bio Recent Developments/Updates
6.6 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bharat Biotech Genetically Engineered Vector Vaccine Product Portfolio
6.6.5 Bharat Biotech Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Genetically Engineered Vector Vaccine Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Zoties
6.8.1 Zoties Corporation Information
6.8.2 Zoties Description and Business Overview
6.8.3 Zoties Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zoties Genetically Engineered Vector Vaccine Product Portfolio
6.8.5 Zoties Recent Developments/Updates
6.9 Elanco
6.9.1 Elanco Corporation Information
6.9.2 Elanco Description and Business Overview
6.9.3 Elanco Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Elanco Genetically Engineered Vector Vaccine Product Portfolio
6.9.5 Elanco Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim Genetically Engineered Vector Vaccine Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 Indian Immunologicals
6.11.1 Indian Immunologicals Corporation Information
6.11.2 Indian Immunologicals Genetically Engineered Vector Vaccine Description and Business Overview
6.11.3 Indian Immunologicals Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Indian Immunologicals Genetically Engineered Vector Vaccine Product Portfolio
6.11.5 Indian Immunologicals Recent Developments/Updates
6.12 Zhongmu Industrial Co., Ltd.
6.12.1 Zhongmu Industrial Co., Ltd. Corporation Information
6.12.2 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Description and Business Overview
6.12.3 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product Portfolio
6.12.5 Zhongmu Industrial Co., Ltd. Recent Developments/Updates
6.13 Qingdao Yibang Bioengineering Co., Ltd.
6.13.1 Qingdao Yibang Bioengineering Co., Ltd. Corporation Information
6.13.2 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Description and Business Overview
6.13.3 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product Portfolio
6.13.5 Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
6.14 Jinyu Biotechnology
6.14.1 Jinyu Biotechnology Corporation Information
6.14.2 Jinyu Biotechnology Genetically Engineered Vector Vaccine Description and Business Overview
6.14.3 Jinyu Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jinyu Biotechnology Genetically Engineered Vector Vaccine Product Portfolio
6.14.5 Jinyu Biotechnology Recent Developments/Updates
6.15 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
6.15.1 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Corporation Information
6.15.2 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Description and Business Overview
6.15.3 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product Portfolio
6.15.5 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
6.16 Tianjin Ruipu Biotechnology
6.16.1 Tianjin Ruipu Biotechnology Corporation Information
6.16.2 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Description and Business Overview
6.16.3 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product Portfolio
6.16.5 Tianjin Ruipu Biotechnology Recent Developments/Updates
6.17 Kyoto Biken Laboratories
6.17.1 Kyoto Biken Laboratories Corporation Information
6.17.2 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Description and Business Overview
6.17.3 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product Portfolio
6.17.5 Kyoto Biken Laboratories Recent Developments/Updates
6.18 FATRO
6.18.1 FATRO Corporation Information
6.18.2 FATRO Genetically Engineered Vector Vaccine Description and Business Overview
6.18.3 FATRO Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 FATRO Genetically Engineered Vector Vaccine Product Portfolio
6.18.5 FATRO Recent Developments/Updates
6.19 Ceva Santé Animale
6.19.1 Ceva Santé Animale Corporation Information
6.19.2 Ceva Santé Animale Genetically Engineered Vector Vaccine Description and Business Overview
6.19.3 Ceva Santé Animale Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Ceva Santé Animale Genetically Engineered Vector Vaccine Product Portfolio
6.19.5 Ceva Santé Animale Recent Developments/Updates
6.20 Pleco
6.20.1 Pleco Corporation Information
6.20.2 Pleco Genetically Engineered Vector Vaccine Description and Business Overview
6.20.3 Pleco Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Pleco Genetically Engineered Vector Vaccine Product Portfolio
6.20.5 Pleco Recent Developments/Updates
6.21 Wuhan Huisheng Biotechnology
6.21.1 Wuhan Huisheng Biotechnology Corporation Information
6.21.2 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Description and Business Overview
6.21.3 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product Portfolio
6.21.5 Wuhan Huisheng Biotechnology Recent Developments/Updates
6.22 Jinhe Biotechnology
6.22.1 Jinhe Biotechnology Corporation Information
6.22.2 Jinhe Biotechnology Genetically Engineered Vector Vaccine Description and Business Overview
6.22.3 Jinhe Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Jinhe Biotechnology Genetically Engineered Vector Vaccine Product Portfolio
6.22.5 Jinhe Biotechnology Recent Developments/Updates
6.23 Shenlian Biotechnology
6.23.1 Shenlian Biotechnology Corporation Information
6.23.2 Shenlian Biotechnology Genetically Engineered Vector Vaccine Description and Business Overview
6.23.3 Shenlian Biotechnology Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Shenlian Biotechnology Genetically Engineered Vector Vaccine Product Portfolio
6.23.5 Shenlian Biotechnology Recent Developments/Updates
6.24 Azure Creatures
6.24.1 Azure Creatures Corporation Information
6.24.2 Azure Creatures Genetically Engineered Vector Vaccine Description and Business Overview
6.24.3 Azure Creatures Genetically Engineered Vector Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Azure Creatures Genetically Engineered Vector Vaccine Product Portfolio
6.24.5 Azure Creatures Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetically Engineered Vector Vaccine Industry Chain Analysis
7.2 Genetically Engineered Vector Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetically Engineered Vector Vaccine Production Mode & Process
7.4 Genetically Engineered Vector Vaccine Sales and Marketing
7.4.1 Genetically Engineered Vector Vaccine Sales Channels
7.4.2 Genetically Engineered Vector Vaccine Distributors
7.5 Genetically Engineered Vector Vaccine Customers
8 Genetically Engineered Vector Vaccine Market Dynamics
8.1 Genetically Engineered Vector Vaccine Industry Trends
8.2 Genetically Engineered Vector Vaccine Market Drivers
8.3 Genetically Engineered Vector Vaccine Market Challenges
8.4 Genetically Engineered Vector Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Genetically Engineered Vector Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Genetically Engineered Vector Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Genetically Engineered Vector Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Genetically Engineered Vector Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Genetically Engineered Vector Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Genetically Engineered Vector Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Genetically Engineered Vector Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Genetically Engineered Vector Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genetically Engineered Vector Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Engineered Vector Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genetically Engineered Vector Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Genetically Engineered Vector Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Genetically Engineered Vector Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Genetically Engineered Vector Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Genetically Engineered Vector Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Genetically Engineered Vector Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Genetically Engineered Vector Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Genetically Engineered Vector Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Genetically Engineered Vector Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Genetically Engineered Vector Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Genetically Engineered Vector Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Genetically Engineered Vector Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Genetically Engineered Vector Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Genetically Engineered Vector Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Genetically Engineered Vector Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Genetically Engineered Vector Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Genetically Engineered Vector Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Genetically Engineered Vector Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Genetically Engineered Vector Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Genetically Engineered Vector Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Genetically Engineered Vector Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Genetically Engineered Vector Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Genetically Engineered Vector Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Genetically Engineered Vector Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Genetically Engineered Vector Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Genetically Engineered Vector Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Genetically Engineered Vector Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Genetically Engineered Vector Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Genetically Engineered Vector Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Genetically Engineered Vector Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Genetically Engineered Vector Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Genetically Engineered Vector Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Genetically Engineered Vector Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Genetically Engineered Vector Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Genetically Engineered Vector Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Genetically Engineered Vector Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Genetically Engineered Vector Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Genetically Engineered Vector Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Genetically Engineered Vector Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Genetically Engineered Vector Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Genetically Engineered Vector Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Genetically Engineered Vector Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Genetically Engineered Vector Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Genetically Engineered Vector Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Genetically Engineered Vector Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Genetically Engineered Vector Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Genetically Engineered Vector Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Genetically Engineered Vector Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GSK Genetically Engineered Vector Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Wantai Biotechnology Corporation Information
Table 86. Wantai Biotechnology Description and Business Overview
Table 87. Wantai Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Wantai Biotechnology Genetically Engineered Vector Vaccine Product
Table 89. Wantai Biotechnology Recent Developments/Updates
Table 90. Watson Bio Corporation Information
Table 91. Watson Bio Description and Business Overview
Table 92. Watson Bio Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Watson Bio Genetically Engineered Vector Vaccine Product
Table 94. Watson Bio Recent Developments/Updates
Table 95. Bharat Biotech Corporation Information
Table 96. Bharat Biotech Description and Business Overview
Table 97. Bharat Biotech Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Bharat Biotech Genetically Engineered Vector Vaccine Product
Table 99. Bharat Biotech Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sanofi Genetically Engineered Vector Vaccine Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Zoties Corporation Information
Table 106. Zoties Description and Business Overview
Table 107. Zoties Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zoties Genetically Engineered Vector Vaccine Product
Table 109. Zoties Recent Developments/Updates
Table 110. Elanco Corporation Information
Table 111. Elanco Description and Business Overview
Table 112. Elanco Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Elanco Genetically Engineered Vector Vaccine Product
Table 114. Elanco Recent Developments/Updates
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Boehringer Ingelheim Genetically Engineered Vector Vaccine Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Indian Immunologicals Corporation Information
Table 121. Indian Immunologicals Description and Business Overview
Table 122. Indian Immunologicals Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Indian Immunologicals Genetically Engineered Vector Vaccine Product
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. Zhongmu Industrial Co., Ltd. Corporation Information
Table 126. Zhongmu Industrial Co., Ltd. Description and Business Overview
Table 127. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product
Table 129. Zhongmu Industrial Co., Ltd. Recent Developments/Updates
Table 130. Qingdao Yibang Bioengineering Co., Ltd. Corporation Information
Table 131. Qingdao Yibang Bioengineering Co., Ltd. Description and Business Overview
Table 132. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product
Table 134. Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
Table 135. Jinyu Biotechnology Corporation Information
Table 136. Jinyu Biotechnology Description and Business Overview
Table 137. Jinyu Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Jinyu Biotechnology Genetically Engineered Vector Vaccine Product
Table 139. Jinyu Biotechnology Recent Developments/Updates
Table 140. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Corporation Information
Table 141. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Description and Business Overview
Table 142. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product
Table 144. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
Table 145. Tianjin Ruipu Biotechnology Corporation Information
Table 146. Tianjin Ruipu Biotechnology Description and Business Overview
Table 147. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product
Table 149. Tianjin Ruipu Biotechnology Recent Developments/Updates
Table 150. Kyoto Biken Laboratories Corporation Information
Table 151. Kyoto Biken Laboratories Description and Business Overview
Table 152. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product
Table 154. Kyoto Biken Laboratories Recent Developments/Updates
Table 155. FATRO Corporation Information
Table 156. FATRO Description and Business Overview
Table 157. FATRO Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. FATRO Genetically Engineered Vector Vaccine Product
Table 159. FATRO Recent Developments/Updates
Table 160. Ceva Santé Animale Corporation Information
Table 161. Ceva Santé Animale Description and Business Overview
Table 162. Ceva Santé Animale Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Ceva Santé Animale Genetically Engineered Vector Vaccine Product
Table 164. Ceva Santé Animale Recent Developments/Updates
Table 165. Pleco Corporation Information
Table 166. Pleco Description and Business Overview
Table 167. Pleco Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Pleco Genetically Engineered Vector Vaccine Product
Table 169. Pleco Recent Developments/Updates
Table 170. Wuhan Huisheng Biotechnology Corporation Information
Table 171. Wuhan Huisheng Biotechnology Description and Business Overview
Table 172. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product
Table 174. Wuhan Huisheng Biotechnology Recent Developments/Updates
Table 175. Jinhe Biotechnology Corporation Information
Table 176. Jinhe Biotechnology Description and Business Overview
Table 177. Jinhe Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Jinhe Biotechnology Genetically Engineered Vector Vaccine Product
Table 179. Jinhe Biotechnology Recent Developments/Updates
Table 180. Shenlian Biotechnology Corporation Information
Table 181. Shenlian Biotechnology Description and Business Overview
Table 182. Shenlian Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Shenlian Biotechnology Genetically Engineered Vector Vaccine Product
Table 184. Shenlian Biotechnology Recent Developments/Updates
Table 185. Azure Creatures Corporation Information
Table 186. Azure Creatures Description and Business Overview
Table 187. Azure Creatures Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Azure Creatures Genetically Engineered Vector Vaccine Product
Table 189. Azure Creatures Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Genetically Engineered Vector Vaccine Distributors List
Table 193. Genetically Engineered Vector Vaccine Customers List
Table 194. Genetically Engineered Vector Vaccine Market Trends
Table 195. Genetically Engineered Vector Vaccine Market Drivers
Table 196. Genetically Engineered Vector Vaccine Market Challenges
Table 197. Genetically Engineered Vector Vaccine Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Genetically Engineered Vector Vaccine
Figure 2. Global Genetically Engineered Vector Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Genetically Engineered Vector Vaccine Market Share by Type in 2023 & 2030
Figure 4. Viral Vector Vaccine Product Picture
Figure 5. Plasmid Vector Vaccine Product Picture
Figure 6. VLPV Product Picture
Figure 7. RNA Vaccine Product Picture
Figure 8. Global Genetically Engineered Vector Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Genetically Engineered Vector Vaccine Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Genetically Engineered Vector Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Genetically Engineered Vector Vaccine Market Size (2019-2030) & (US$ Million)
Figure 15. Global Genetically Engineered Vector Vaccine Sales (2019-2030) & (K Units)
Figure 16. Global Genetically Engineered Vector Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 17. Genetically Engineered Vector Vaccine Report Years Considered
Figure 18. Genetically Engineered Vector Vaccine Sales Share by Manufacturers in 2023
Figure 19. Global Genetically Engineered Vector Vaccine Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Genetically Engineered Vector Vaccine Players: Market Share by Revenue in 2023
Figure 21. Genetically Engineered Vector Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Genetically Engineered Vector Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Genetically Engineered Vector Vaccine Sales Market Share by Country (2019-2030)
Figure 24. North America Genetically Engineered Vector Vaccine Revenue Market Share by Country (2019-2030)
Figure 25. United States Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Genetically Engineered Vector Vaccine Sales Market Share by Country (2019-2030)
Figure 28. Europe Genetically Engineered Vector Vaccine Revenue Market Share by Country (2019-2030)
Figure 29. Germany Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Netherlands Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Genetically Engineered Vector Vaccine Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Genetically Engineered Vector Vaccine Revenue Market Share by Region (2019-2030)
Figure 36. China Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Genetically Engineered Vector Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Genetically Engineered Vector Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Genetically Engineered Vector Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Genetically Engineered Vector Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Genetically Engineered Vector Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Genetically Engineered Vector Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Genetically Engineered Vector Vaccine by Type (2019-2030)
Figure 55. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Genetically Engineered Vector Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Genetically Engineered Vector Vaccine by Application (2019-2030)
Figure 58. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 59. Genetically Engineered Vector Vaccine Value Chain
Figure 60. Genetically Engineered Vector Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed